carnitine has been researched along with Sclerosis, Systemic in 9 studies
Excerpt | Relevance | Reference |
---|---|---|
"L-propionylcarnitine (L-PC) is a metabolic substance that is associated with a beneficial effect on both microcirculation and myocyte function." | 2.73 | Effect of a single IV administration of L-propionylcarnitine on myocardial microcirculation assessed by coronary flow velocity reserve measurement in patients with systemic sclerosis: a pilot study. ( Cauli, A; Iliceto, S; Lai, S; Mathieu, A; Meloni, L; Montisci, M; Montisci, R; Passiu, G; Ruscazio, M; Vacca, A, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (55.56) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Ottria, A | 1 |
Hoekstra, AT | 1 |
Zimmermann, M | 1 |
van der Kroef, M | 1 |
Vazirpanah, N | 1 |
Cossu, M | 1 |
Chouri, E | 1 |
Rossato, M | 1 |
Beretta, L | 2 |
Tieland, RG | 1 |
Wichers, CGK | 1 |
Stigter, E | 1 |
Gulersonmez, C | 1 |
Bonte-Mineur, F | 1 |
Berkers, CR | 1 |
Radstake, TRDJ | 1 |
Marut, W | 1 |
Fernández-Ochoa, Á | 1 |
Quirantes-Piné, R | 1 |
Borrás-Linares, I | 1 |
Gemperline, D | 1 |
Alarcón Riquelme, ME | 1 |
Segura-Carretero, A | 1 |
Montisci, R | 1 |
Ruscazio, M | 1 |
Lai, S | 1 |
Vacca, A | 1 |
Cauli, A | 1 |
Passiu, G | 1 |
Montisci, M | 1 |
Meloni, L | 1 |
Mathieu, A | 1 |
Iliceto, S | 1 |
Famularo, G | 1 |
De Simone, C | 1 |
Danese, C | 1 |
Nitzschner, H | 3 |
Schneider, D | 1 |
Liebsch, F | 2 |
Strack, E | 1 |
Nitschner, H | 1 |
1 review available for carnitine and Sclerosis, Systemic
Article | Year |
---|---|
Carnitine deficiency in scleroderma.
Topics: Antioxidants; Carnitine; Humans; Scleroderma, Systemic | 1999 |
1 trial available for carnitine and Sclerosis, Systemic
Article | Year |
---|---|
Effect of a single IV administration of L-propionylcarnitine on myocardial microcirculation assessed by coronary flow velocity reserve measurement in patients with systemic sclerosis: a pilot study.
Topics: Adenosine; Adult; Aged; Blood Flow Velocity; Cardiotonic Agents; Cardiovascular Diseases; Carnitine; | 2007 |
7 other studies available for carnitine and Sclerosis, Systemic
Article | Year |
---|---|
Fatty Acid and Carnitine Metabolism Are Dysregulated in Systemic Sclerosis Patients.
Topics: Adult; Aged; Carnitine; Cohort Studies; Cytokines; Dendritic Cells; Etoposide; Fatty Acids; Female; | 2020 |
Urinary and plasma metabolite differences detected by HPLC-ESI-QTOF-MS in systemic sclerosis patients.
Topics: Acylation; Adult; Aged; Arachidonic Acids; Biomarkers; Carnitine; Case-Control Studies; Chromatograp | 2019 |
[Observations of the course of scleroderma after combined Hylase-carnitine therapy].
Topics: Carnitine; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Humans; Hyaluronoglucosaminid | 1975 |
[Treatment of progressive scleroderma using carnitine].
Topics: Adult; Blood Circulation; Carnitine; Dextrans; Drug Eruptions; Drug Evaluation; Drug Tolerance; Elas | 1974 |
[The course of scleroderma following treatment with carnitin].
Topics: Adult; Carnitine; Child; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Middle Aged | 1974 |
[Use of carnitine in connective tissue diseases].
Topics: Adult; Carnitine; Collagen Diseases; Female; Humans; Hyperthyroidism; Male; Middle Aged; Scleroderma | 1971 |
[Carnitine and diseases of the connective tissue].
Topics: Adult; Aged; Carnitine; Child; Collagen Diseases; Dermatomyositis; Dupuytren Contracture; Female; Hu | 1970 |